BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28629174)

  • 1. Using Coexpression Protein Interaction Network Analysis to Identify Mechanisms of Danshensu Affecting Patients with Coronary Heart Disease.
    Huo M; Wang Z; Wu D; Zhang Y; Qiao Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629174
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network.
    Wu D; Huo M; Chen X; Zhang Y; Qiao Y
    BMC Complement Med Ther; 2020 Feb; 20(1):28. PubMed ID: 32020855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the protective mechanism of Huoxue Anxin Recipe against coronary heart disease by network analysis and experimental validation.
    Wang J; Zhang Y; Liu YM; Yang XC; Chen YY; Wu GJ; He XH; Duan L; Dong Y; Ma RF
    Biomed Pharmacother; 2020 Jan; 121():109655. PubMed ID: 31734577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics.
    Jiang Y; He Q; Zhang T; Xiang W; Long Z; Wu S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring mechanisms of Panax notoginseng saponins in treating coronary heart disease by integrating gene interaction network and functional enrichment analysis.
    Yu G; Wang J
    Chin J Integr Med; 2016 Aug; 22(8):589-96. PubMed ID: 27184904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circRNA‑miRNA association for coronary heart disease.
    Lin F; Zhao G; Chen Z; Wang X; Lv F; Zhang Y; Yang X; Liang W; Cai R; Li J; Li M; Zhang G
    Mol Med Rep; 2019 Apr; 19(4):2527-2536. PubMed ID: 30720076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
    Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases.
    Li G; Xu Q; Han K; Yan W; Huang C
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32990315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network pharmacology approach to reveal the protective mechanism of Salvia miltiorrhiza-Dalbergia odorifera coupled-herbs on coronary heart disease.
    Li F; Duan J; Zhao M; Huang S; Mu F; Su J; Liu K; Pan Y; Lu X; Li J; Wei P; Xi M; Wen A
    Sci Rep; 2019 Dec; 9(1):19343. PubMed ID: 31852981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Signature for Smoking Status of Coronary Heart Disease Patients through Weighted Gene Coexpression Network Analysis.
    Shang Z; Sun J; Hui J; Yu Y; Bian X; Yang B; Deng K; Lin L
    Comput Math Methods Med; 2022; 2022():5777946. PubMed ID: 35096131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A module of multifactor-mediated dysfunction guides the molecular typing of coronary heart disease.
    Li Y; Lin M; Wang K; Zhan Y; Gu W; Gao G; Huang Y; Chen Y; Huang T; Wang J
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1415. PubMed ID: 32743916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats.
    Tang Y; Wang M; Le X; Meng J; Huang L; Yu P; Chen J; Wu P
    Phytomedicine; 2011 Sep; 18(12):1024-30. PubMed ID: 21665454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels.
    Lam FF; Yeung JH; Chan KM; Or PM
    Vascul Pharmacol; 2007 Apr; 46(4):271-7. PubMed ID: 17188580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems biology framework identifies molecular underpinnings of coronary heart disease.
    Huan T; Zhang B; Wang Z; Joehanes R; Zhu J; Johnson AD; Ying S; Munson PJ; Raghavachari N; Wang R; Liu P; Courchesne P; Hwang SJ; Assimes TL; McPherson R; Samani NJ; Schunkert H; ; Meng Q; Suver C; O'Donnell CJ; Derry J; Yang X; Levy D
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1427-34. PubMed ID: 23539213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Based on Serum Pharmacochemistry and Virtual Screening Technique Analysis Used to Explore the Potential Active Ingredients and Possible Anti- Coronary Heart Disease Mechanisms of Salvia miltiorrhiza Bunge.
    Shi Y; Li Q; Zhu J; Hou CW; Li XL; Liu XD; Tong QZ
    Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38204249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages.
    Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W
    Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative pharmacokinetic study of sodium Danshensu and Salvia miltiorrhiza injection in rat].
    Wang J; Ma Z; Wang W; Hong Z; Song J
    Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(22):2943-5. PubMed ID: 20209966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the multi-targets mechanism of triphala on cardio-cerebral vascular diseases based on network pharmacology.
    Wang W; Liu T; Yang L; Ma Y; Dou F; Shi L; Wen A; Ding Y
    Biomed Pharmacother; 2019 Aug; 116():108994. PubMed ID: 31112872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Network pharmacology study on major active compounds of Fufang Danshen formula].
    Li X; Wu L; Fan X; Zhang B; Gao X; Wang Y; Cheng Y
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):2911-5. PubMed ID: 22308672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.